Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Net Income (2016 - 2025)

Standard Biotools (LAB) has disclosed Net Income for 16 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 178.01% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$39.4 million through Dec 2025, up 38.71% year-over-year, with the annual reading at -$16.1 million for FY2025, 66.48% up from the prior year.
  • Net Income for Q4 2025 was $5.4 million at Standard Biotools, up from -$3.0 million in the prior quarter.
  • The five-year high for Net Income was $13.7 million in Q4 2023, with the low at -$76.3 million in Q1 2022.
  • Average Net Income over 5 years is -$20.3 million, with a median of -$17.2 million recorded in 2021.
  • The sharpest move saw Net Income plummeted 305.82% in 2022, then skyrocketed 178.01% in 2025.
  • Over 5 years, Net Income stood at -$13.9 million in 2021, then plummeted by 50.34% to -$20.8 million in 2022, then surged by 165.83% to $13.7 million in 2023, then plummeted by 150.27% to -$6.9 million in 2024, then surged by 178.01% to $5.4 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at $5.4 million, -$3.0 million, and -$15.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.